Immunization of rats against Fasciola hepatica using crude antigens conjugated with Freund's adjuvant or oligodeoxynucleotides

Veterinary Immunology and Immunopathology

Volumn 97, Issue 1-2, 2004, Pages 97-104

  Cervi, Laura ^a   Borgonovo, Janina ^a   Egea, Mariela ^a   Chiapello, Laura ^a   Masih, Diana ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

F. hepatica; Freund's adjuvant; Oligodeoxynucleotide; Protection; Rats infection

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 4; OLIGODEOXYNUCLEOTIDE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; FASCIOLIASIS; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; LYMPH NODE CELL; NONHUMAN; RAT; TH1 CELL;

ANIMALIA; DIGENEA (FLUKES); FASCIOLA; FASCIOLA HEPATICA; HEPATICA; RATTUS NORVEGICUS;

EID: 0347416774     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2003.08.015     Document Type: Article

References (29)

1. Baeza E., Poitou L., Delers F., Boulard C. Influence of anti-inflammatory treatments on experimental infection of rats with Fasciola hepatica: changes in serum levels of inflammatory markers during the early stages of fasciolosis. Res. Vet. Sci. 57:1994;180-187.
2. Boray, J.C., 1985. In: Gaafar, S.M., Howard, W.E., Marsh, E. (Eds.), Parasites, Pest and Predators. Elsevier, Amsterdam, pp. 179-218.
3. Brewer J.M., Alexander J. Cytokines and the mechanisms of action of vaccine adjuvants. Cytokines Cell. Mol. Ther. 3:1997;233-246.
4. Cervi L., Rubinstein H.R., Masih D.T. Involvement of excretion-secretion products from Fasciola hepatica inducing suppression of the cellular immune responses. Vet. Parasitol. 61:1996;97-111.
5. Cervi L., Cejas H., Masih D.T. Cytokines involved in the immunosuppressor period in experimental fasciolosis in rats. Int. J. Parasitol. 31:2001;1467-1473.
6. Chauvin A., Bouvet G., Boulard C. Humoral and cellular immune responses to Fasciola hepatica experimental primary and secondary infection in sheep. Int. J. Parasitol. 25:1995;1227-1241.
7. Chiaramonte M.G., Hesse M., Cheever A.W., Wynn T.A. CpG oligonucleotides can prophylactically immunize against Th2-mediated Schistosome egg-induced pathology by an IL-12-independent mechanism. J. Immunol. 164:2000;973-985.
8. Clery D., Torgerson P., Mulcahy G. Immune responses of chronically infected adult cattle to Fasciola hepatica. Vet. Parasitol. 62:1996;71-82.
9. Eriksen L., Flagstad T. Fasciola hepatica: influence of extrahepatic adult flukes on infections and immunity in rats. Exp. Parasitol. 105:1974;411-417.
10. Gupta, R.K., Relyveld, E.H., Lindblad, 1993. Adjuvants - a balance between toxicity and adjuvancity. Vaccine 11, 293-295.
11. Haroun E.M., Hillyer G.V. Resistance to fascioliasis: a review. Vet. Parasitol. 20:1986;63-93.
12. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;659-660.
13. Huges, D.L., 1987. Fasciola and fascioloides. In: Soulsby, E.J.L. (Ed.), Immune Responses in Parasitic Infections: Immunology, Immunopathology, and Immunoprophylaxis, vol. II, Trematodes and Cestodes. CRC Press, Boca Raton, FL, pp. 91-114.
14. Krieg A.M., Love-Homan L., Yi A.K., Harty J.T. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161:1998;2428-2435.
15. Modlin R.L. A Toll for DNA vaccines. Nature. 408:2000;659-660.
16. Moldoveanu Z., Love-Homan L., Huang W.Q., Krieg A.M. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine. 16:1998;1216-1222.
17. Mulcahy, G., Joyce, P., Dalton, J.P., 1999. Immunology of Fasciola hepatica infection. In: Dalton, J.P. (Ed.), Fasciolosis. CAB International, Oxon, UK, pp. 341-376.
18. Oldham G., Huges D.L. Fasciola hepatica: immunization of rats by intraperitoneal injection of adult fluke antigen in Freund's adjuvant. Exp. Parasitol. 54:1982;7-11.
19. Pfister K. Role of IgE in fascioliasis. Prev. Vet. Med. 2:1984;359-370.
20. Piedrafita D., Parson J.C., Sandeman R.M., Wood P.R., Estuningsih S.E., Partouto S., Spithill T.W. Antibody-dependent cell-mediated cytotoxicity to newly excysted juvenile Fasciola hepatica in vitro is mediated by reactive nitrogen intermediates. Parasite Immunol. 9:2001;473-482.
21. Poitou I., Baeza E., Boulard C. Kinetic responses of parasite-specific antibody isotypes, blood leucocyte pattern and lymphocyte subsets in rats during primary infestation with Fasciola hepatica. Vet. Parasitol. 49:1993;179-190.
22. Roberts J.A., Estuningsih E., Widjayanti S., Wiedosari E., Partoutomo S., Spithill T.W. Resistance of Indonesian thin tail sheep against Fasciola gigantica and F. hepatica. Vet. Parasitol. 68:1997;69-78.
23. Sabder B., Hoiden I., Andersson U., Moller E., Abrams J.S. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. J. Immunol. Meth. 166:1993;201-214.
24. Sai-Kiang L. Freund adjuvant induces TLR3 but not TLR4 expression in the liver of mice. Int. Immunopharm. 3:2003;115-118.
25. Suhardono, Widjajanti, S., Stevenson, P., Carmichael, I.H., 1991. Control of Fasciola gigantica with triclabendazole in Indonesian cattle. Trop. Anim. Health Prod. 23, 217-220.
26. Walker P.S., Scharton-Kersten T., Krieg A.M., Love-Homan L., Rowton E.D., Udey M.C., Vogel J.C. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-γ-dependent mechanisms. Proc. Natl. Acad. Sci. USA. 96:1999;6970-6975.
27. Warren H.S., Vogel F.R., Chedid L.A. Current status of immunological adjuvants. Annu. Rev. Immunol. 4:1986;369-375.
28. Zimmerman G.L., Isaacson Kerkvliet N., Brauner J.A., Cerro J.E. Modulation of host immune responses by Fasciola hepatica: responses of peripheral lymphocytes to mitogens during liver fluke infections of sheep. J. Parasitol. 69:1983;473-477.
29. Zimmerman S., Egeter O., Hausmann S., Lipford G.B., Rocken M., Wagner H., Heeg K. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160:1998;3627-3634.